ArticleClinical pharmacology and therapeutics2026

Straight to Phase III: Model-Informed Approach Speeds Depemokimab Clinical Development in Interleukin-5-Driven Diseases.

Chiara Zecchin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.